Valuation : EBOS Group Limited

Market Cap 350.12Cr 252.37Cr 217.17Cr 204.32Cr 186.65Cr 349.17Cr 24TCr 2.41TCr 936.91Cr 12TCr 947.69Cr 927.02Cr 39TCr P/E 2027 *
14.9x
P/E 2028 * 13.2x
Enterprise Value 451.48Cr 325.44Cr 280.04Cr 263.48Cr 240.69Cr 450.25Cr 31TCr 3.11TCr 1.21TCr 16TCr 1.22TCr 1.2TCr 51TCr EV / Sales 2027 *
0.32x
EV / Sales 2028 * 0.31x
Free-Float
89.8%
Yield 2027 *
5.61%
Yield 2028 * 6.08%
3 years 20.02
Extreme 20.02
23.75
5 years 20.02
Extreme 20.02
28.25
10 years 20.02
Extreme 20.02
28.25
Manager TitleAgeSince
Chief Executive Officer 51 01/07/2025
Director of Finance/CFO - 30/09/2024
Chief Tech/Sci/R&D Officer - 01/08/2023
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 01/07/2019
Director/Board Member 60 01/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+15.85%-.--% - - 252.37Cr
-1.45%+1.63%+32.09%+123.02% 11TCr
-0.58%+5.38%+65.27%+184.41% 5.75TCr
+0.37%+0.75%-11.18%+248.39% 2.24TCr
+1.09%+1.28%-9.33%-5.62% 826.12Cr
-0.33%-1.05%-37.27%-28.46% 714.96Cr
-0.59%+6.52%+6.47%+28.26% 679.03Cr
+1.49%-1.51%-15.46%-25.82% 624.43Cr
-0.24%-1.72%-5.85%+20.23% 510.18Cr
+1.71%+6.91%+323.81%+481.22% 456.37Cr
Average +1.73%+2.54%+38.73%+113.96% 2.49TCr
Weighted average by Cap. -0.53%+3.54%+35.52%+139.67%

Financials

2027 *2028 *
Net sales 1.4TCr 1.01TCr 870.4Cr 818.93Cr 748.09Cr 1.4TCr 96TCr 9.68TCr 3.76TCr 49TCr 3.8TCr 3.72TCr 1,57900Cr 1.47TCr 1.06TCr 909.12Cr 855.36Cr 781.37Cr 1.46TCr 1LCr 10TCr 3.92TCr 51TCr 3.97TCr 3.88TCr 1,64900Cr
Net income 23Cr 17Cr 14Cr 13Cr 12Cr 23Cr 1.56TCr 158.17Cr 61Cr 800.9Cr 62Cr 61Cr 2.58TCr 26Cr 19Cr 16Cr 15Cr 14Cr 26Cr 1.78TCr 180.06Cr 70Cr 911.74Cr 71Cr 69Cr 2.94TCr
Net Debt 101.36Cr 73Cr 63Cr 59Cr 54Cr 101.08Cr 6.9TCr 698.98Cr 271.23Cr 3.54TCr 274.35Cr 268.37Cr 11TCr 97Cr 70Cr 60Cr 57Cr 52Cr 97Cr 6.63TCr 672.14Cr 260.82Cr 3.4TCr 263.82Cr 258.06Cr 11TCr
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
16.92AUD
Average target price
23.56AUD
Spread / Average Target
+39.25%

Quarterly revenue - Rate of surprise